These findings generate biologically plausible hypotheses for tumor progression and provide practical clinical tools, as TTF1, LDH, and CRP are easily measurable biomarkers that can support patient stratification, guide surveillance, and inform treatment decisions. Here, CRP is linked to neoplasm.